Hormone Receptor Testing Rarely Guided Endocrine Therapy for Breast DCIS in New Zealand
A 23-year New Zealand population study found that oestrogen receptor testing and endocrine therapy for DCIS remained rare nationally, driven ...
A 23-year New Zealand population study found that oestrogen receptor testing and endocrine therapy for DCIS remained rare nationally, driven ...
A large U.S. real-world study found that ESR1 mutations emerging during first-line therapy for ER-positive metastatic breast cancer are linked ...
In an ambitious stride toward optimizing treatment for hormone receptor-positive (HR+)/HER2-negative advanced breast cancer, a recent comprehensive network meta-analysis has ...
© 2025 Scienmag - Science Magazine
© 2025 Scienmag - Science Magazine